Laurus Labs Joins Dow Jones Best-in-Class World Index for First Time

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Laurus Labs Joins Dow Jones Best-in-Class World Index for First Time
Overview

Laurus Labs has been included in the prestigious Dow Jones Best-in-Class (DJ BIC) World Index for the first time. This recognition highlights the company's improved ESG performance and commitment to sustainable and ethical corporate governance.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Laurus Labs Earns Spot in Dow Jones Best-in-Class World Index

Laurus Labs Limited has achieved a significant milestone, marking its debut in the Dow Jones Best-in-Class (DJ BIC) World Index. This inclusion underscores the company's strong commitment to environmental, social, and governance (ESG) practices and ethical corporate governance.

Debut in Global Sustainability Index

The pharmaceutical company's entry into the DJ BIC World Index is a landmark achievement, representing its first appearance in these globally recognized sustainability indices.

Significance for Investors

This inclusion signifies Laurus Labs's dedication to sustainable and ethical business practices, positioning it among the world's top ESG performers and enhancing its appeal to global investors focused on sustainability.

Building on Past Success

The achievement follows Laurus Labs's recognition in the S&P Global Sustainability Yearbook 2026. The company significantly improved its S&P Global Corporate Sustainability Assessment (CSA) score to 81 out of 100, up from 71 in the prior year, within the pharmaceutical companies category.

Enhanced Credibility

Laurs Labs's presence in the DJ BIC indices is expected to bolster its global investor credibility and solidify its reputation as a sustainability leader.

Maintaining Position

While a positive development, the company must continue to improve its ESG scores to retain its place in these indices, especially with evolving global sustainability standards.

Industry Recognition Benefits

Pharmaceutical companies recognized for strong ESG performance often attract a wider base of institutional investors and may benefit from a valuation premium.

Key Metrics

Laurus Labs's S&P Global CSA score improved to 81/100 in the latest assessment, a notable increase from 71/100 previously.

Future Focus

Investors will be watching Laurus Labs's ongoing ESG initiatives and future sustainability assessment scores to see if the company can maintain and enhance its standing in global sustainability benchmarks.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.